Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma

被引:25
|
作者
Bialy, TL [1 ]
Rothe, MJ [1 ]
Grant-Kels, JM [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Dept Dermatol, Farmington, CT 06030 USA
关键词
D O I
10.1046/j.1524-4725.2002.02114.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. The endogenous antioxidant system of the skin scavenges reactive oxygen species and combats ultraviolet induced oxidative skin damage. Supporting this cutaneous defense system with topical or oral antioxidants may provide a successful strategy for the treatment and prevention of skin cancer. OBJECTIVE. Review evidence regarding treatment and prevention of melanoma and nonmelanoma skin cancers through dietary and topical antioxidants, vitamins, and herbal supplements. METHODS. Literature review. RESULTS. Review of the literature demonstrates that the administration of synthetic retinoids has not proved beneficial for otherwise healthy patients with nonmelanoma skin cancer. Selenium supplementation has reduced the incidence of several internal malignancies but not of nonmelanoma skin cancer. Synergistic use of beta-carotene with vitamins C and E has demonstrated prophylaxis against reactive oxygen radicals involved in nonmelanoma skin cancer and reduced sunburn reactions significantly. 1,25-dihydroxyvitamin D3 analog CB1093 has demonstrated promise as a therapeutic agent in the regression of the early stages of melanoma in specific cell lines. CONCLUSION. Delivery of exogenous antioxidants in combination appears to be a more successful strategy for enhancing the cutaneous antioxidant system than the administration of isolated antioxidants alone. Vitamin D analogs may have a role in the medical therapy of melanoma. However, avoiding exposure to ultraviolet light appears to be the only true panacea against the development of melanoma and NMSC.
引用
收藏
页码:1143 / 1152
页数:10
相关论文
共 50 条
  • [21] Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer
    Julie Rouette
    Hui Yin
    Anton Pottegård
    Krishnarajah Nirantharakumar
    Laurent Azoulay
    Drug Safety, 2021, 44 : 245 - 254
  • [22] Nonmelanoma skin cancer in persons with prior cutaneous melanoma
    Kroumpouzos, G
    Cabral, H
    Karakousis, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 537 - 537
  • [23] Costs of illness for melanoma and nonmelanoma skin cancer in Denmark
    Bentzen, Joan
    Kjellberg, Jakob
    Thorgaard, Camilla
    Engholm, Gerda
    Phillip, Anja
    Storm, Hans H.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2013, 22 (06) : 569 - 576
  • [24] Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer
    Rouette, Julie
    Yin, Hui
    Pottegard, Anton
    Nirantharakumar, Krishnarajah
    Azoulay, Laurent
    DRUG SAFETY, 2021, 44 (02) : 245 - 254
  • [25] Lasers in the Treatment of Nonmelanoma Skin Cancer
    Choudhary, Sonal
    Tang, Jennifer
    Elsaie, Mohamed L.
    Nouri, Keyvan
    DERMATOLOGIC SURGERY, 2011, 37 (04) : 409 - 425
  • [26] Epidemiology of melanoma and nonmelanoma skin cancer - The role of sunlight
    Leiter, Ulrike
    Garbe, Claus
    SUNLIGHT, VITAMIN D AND SKIN CANCER, 2008, 624 : 89 - 103
  • [27] Nonsurgical Treatment of Nonmelanoma Skin Cancer
    Galiczynski, Edward M.
    Vidimos, Allison T.
    DERMATOLOGIC CLINICS, 2011, 29 (02) : 297 - +
  • [28] Treatment of Nonmelanoma Skin Cancer Reply
    Linos, Eleni
    Landefeld, Charles Seth
    Chren, Mary Margaret
    JAMA INTERNAL MEDICINE, 2013, 173 (22) : 2097 - 2097
  • [29] Current Research in Melanoma and Aggressive Nonmelanoma Skin Cancer
    Wilken, Reason
    Criscito, Maressa
    Pavlick, Anna C.
    Stevenson, Mary L.
    Carucci, John A.
    FACIAL PLASTIC SURGERY, 2020, 36 (02) : 200 - 210
  • [30] SKIN-CANCER - MELANOMA AND OTHER SPECIFIC NONMELANOMA SKIN CANCERS
    ELDER, DE
    CANCER, 1995, 75 (01) : 245 - 256